TD Asset Management
AMLX icon

TD Asset Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

TD Asset Management’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-131,200
Closed -$373K – 1365
2024
Q1 		$373K Buy
131,200
+16,200
+14% +$46K ﹤0.01% 1324
2023
Q4 		$1.69M Buy
+115,000
New +$1.69M ﹤0.01% 1061